Nanoplasmonic multiplex biosensing for COVID-19 vaccines

The ongoing emergence of severe acute respiratory syndrome caused by the new coronavirus (SARS-CoV-2) variants requires swift actions in identifying specific antigens and optimizing vaccine development to maximize the humoral response of the patient. Measuring the specificity and the amount of antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Funari, Riccardo, Fukuyama, Hidehiro, Shen, Amy Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968208/
https://www.ncbi.nlm.nih.gov/pubmed/35421841
http://dx.doi.org/10.1016/j.bios.2022.114193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968208/
https://www.ncbi.nlm.nih.gov/pubmed/35421841
http://dx.doi.org/10.1016/j.bios.2022.114193

Ejemplares similares